-

IFF Appoints Paul J. Fribourg and Jesus B. Mantas to Board of Directors

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients, health and biosciences—today announced the appointment of Paul J. Fribourg and Jesus B. Mantas to its board of directors, effective immediately.

These appointments bring extensive international leadership experience, and industry and strategic insight to IFF as the company continues to advance its innovation agenda and strengthen its market position.

“I am delighted that Paul and Jesus are joining the IFF board,” said Kevin O’Byrne, chair of the IFF board. “They bring a strong combination of digital innovation, global market insight and operational excellence. Their experience, leadership and vision will help guide IFF through its next phase of growth as we continue to deliver breakthrough solutions for customers and create long-term value for our stakeholders.”

Paul J. Fribourg

Fribourg brings more than four decades of global leadership experience in agribusiness, food and investment sectors, and currently serves as Chairman and Chief Executive Officer of Continental Grain Company, a position he has held since 1976. Fribourg has overseen the company’s transformation into a diversified global investment firm with a focus on food, agriculture and adjacent industries. Under his leadership, Continental Grain Company has expanded its portfolio and strategic partnerships across continents, reinforcing its legacy of innovation and resilience.

He serves as lead independent director of Loews Corp. and sits on the boards of The Estée Lauder Companies Inc., Syngenta Group Co. Ltd. and Wayne-Sanderson Farms LLC. Fribourg is also a member of the Rabobank International North American Agribusiness Advisory Board, the Council on Foreign Relations, the Temasek Americas Advisory Panel and the International Business Leaders Advisory Council for the mayor of Shanghai.

Jesus B. Mantas

Jesus Mantas is a leader in artificial intelligence, business transformation and innovation. He recently retired from IBM, where he served as global managing partner leading the $10 billion Business Transformation Services unit in IBM Consulting.

Before that, he led IBM Consulting global strategy, offerings and acquisitions. He also oversaw several global divisions, including IBM Global Business Outsourcing, IBM Consulting in Latin America, and IBM Consulting in the North America enterprise market. Prior to joining IBM, he was a partner in the technology practice at PricewaterhouseCoopers Consulting.

Mantas currently serves on the board of directors at Biogen Inc., where he chairs the Compensation and Management Development Committee. He is vice chair of the board at HITEC, a nonprofit that promotes and celebrates technology leadership in the Hispanic community. He also serves as a council member of the Council on Global Competition and Innovation, a nonpartisan, nonprofit organization focused on accelerating innovation investments in national security.

He was a member of the World Economic Forum’s AI Global Council, served as an adjunct professor at the University of California, Irvine Graduate School of Management, and was an officer in the Spanish Air Force.

Welcome to IFF

At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—advancing wellness, delighting the senses and enhancing the human experience. Learn more at iff.com, LinkedIn, Instagram and Facebook.

© 2025 by International Flavors & Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved.

Contacts

Media Relations:
Paulina Heinkel
332.877.5339
Media.request@iff.com

Investor Relations:
Michael Bender
212.708.7263
Investor.Relations@iff.com

IFF

NYSE:IFF

Release Versions

Contacts

Media Relations:
Paulina Heinkel
332.877.5339
Media.request@iff.com

Investor Relations:
Michael Bender
212.708.7263
Investor.Relations@iff.com

More News From IFF

IFF to Release First Quarter 2026 Results on May 5, 2026

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) today announced that it will release its first quarter 2026 earnings results following the market close on Tuesday, May 5, 2026. The management team will host a live webcast on Wednesday, May 6, 2026, at 9:00 a.m. ET to discuss results and outlook with the investor community. Investors may access the live webcast and accompanying slide presentation on the company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded versio...

IFF Explores the Science Behind Well-Being at In‑Cosmetics Global 2026

PARIS, France--(BUSINESS WIRE)--IFF (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients and health & biosciences—will showcase scent and bioscience innovations focused on wellness and sustainability at In‑Cosmetics Global 2026, taking place April 14–16 at the Paris Expo Porte de Versailles. Across the event, including experiences and live sessions, IFF will illustrate how science‑led ingredients can enhance daily beauty routines and scent experiences, delivering physical an...

IFF Launches PureStrong™, a Probiotic Made Specifically for Dogs

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF)—a global leader in flavors, fragrances, food ingredients and health & biosciences—is introducing PureStrong™, a new probiotic developed exclusively for canine digestive health. Today, many people consider their pet dogs part of the family. This shift is fueling rapid growth in the $3.2 billion U.S. pet supplement market. With nearly half of U.S. pet owners having purchased or considering probiotics for their dogs, PureStrong™ sets a new standard: p...
Back to Newsroom